Immunohistochemical Ki67 after short-term hormone therapy identifies low-risk breast cancers as reliably as genomic markers

BACKGROUND: The purpose of this study was to test whether immunohistochemical (IHC) Ki67 levels after short-term preoperative hormone therapy (post-Ki67) predict similar numbers of patients with favorable prognoses as genomic markers. RESULTS: Thirty paired cases (60 samples) were enrolled in this s...

Descripción completa

Detalles Bibliográficos
Autores principales: Iwamoto, Takayuki, Katagiri, Toyomasa, Niikura, Naoki, Miyoshi, Yuichiro, Kochi, Mariko, Nogami, Tomohiro, Shien, Tadahiko, Motoki, Takayuki, Taira, Naruto, Omori, Masako, Tokuda, Yutaka, Fujiwara, Toshiyoshi, Doihara, Hiroyoshi, Gyorffy, Balazs, Matsuoka, Junji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5432244/
https://www.ncbi.nlm.nih.gov/pubmed/28412725
http://dx.doi.org/10.18632/oncotarget.15385

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5432244/
https://www.ncbi.nlm.nih.gov/pubmed/28412725
http://dx.doi.org/10.18632/oncotarget.15385

Ejemplares similares